522600-25-5

Basic information

• Product Name: 7-amino-5-(3,4-dichloro-phenyl)-pyrazolo[1,5-a]pyrimidine-2-carboxylic acid
• Synonyms: 7-amino-5-(3,4-dichloro-phenyl)-pyrazolo[1,5-a]pyrimidine-2-carboxylic acid
• CAS NO: 522600-25-5
• Molecular Weight: 323.138
• Mol File: 522600-25-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 7-amino-5-(3,4-dichloro-phenyl)-pyrazolo[1,5-a]pyrimidine-2-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 7-amino-5-(3,4-dichloro-phenyl)-pyrazolo[1,5-a]pyrimidine-2-carboxylic acid(522600-25-5)
• EPA Substance Registry System: 7-amino-5-(3,4-dichloro-phenyl)-pyrazolo[1,5-a]pyrimidine-2-carboxylic acid(522600-25-5)

Safety Data

• Hazardous Substances Data: 522600-25-5(Hazardous Substances Data)

Upstream product

• 124004-31-5 5-amino-1H-pyrazole-3-carboxylic acid 
• 4640-68-0 3,4-dichlorobenzoyl acetonitrile 

Downstream Products

• 522599-87-7 7-amino-5-(3,4-dichloro-phenyl)-pyrazolo[1,5-a]pyrimidine-2-carboxylic acid benzylamide 

Relevant articles and documents

Pyrazolopyrimidines

Compounds, compositions and methods are provided which are useful in the treatment of diseases through the inhibition of sodium ion flux through voltage-dependent sodium channels. More particularly, the invention provides pyrazolopyrimidines, compositions and methods that are useful in the treatment of central or peripheral nervous system disorders, particularly pain and chronic pain by blocking sodium channels associated with the onset or recurrance of the indicated conditions. The compounds, compositions and methods of the present invention are of particular use for treating neuropathic or inflammatory pain by the inhibition of ion flux through a channel that includes a PN3 subunit.